Charlottesville Medical Research

Clinical research site in Charlottesville, Virginia · Charlottesville Medical Research, 325 Winding River Ln #102, Charlottesville, VA 22911 · (434) 817-2442 · Website

4.8on Google· View on Google Maps

As of September 2026, 14 paid clinical trials are recruiting at Charlottesville Medical Research in Charlottesville, Virginia. Active studies at this site cover conditions such as Osteoarthritis, Gout and Hypercholesterolemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

New trial at Charlottesville Medical Research? We'll email you when one opens.

Recruiting clinical trials at Charlottesville Medical Research (14)

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

for Hypercholesterolemia

34 locations incl. Anniston

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18 - 80

Code: NCT07477704·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for Osteoarthritis

38 locations incl. Mobile

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07353931·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

A Study of Dotinurad Versus Allopurinol in Participants With Gout

for Gout

70 locations incl. Birmingham

Sponsor: Crystalys Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07089875·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for Tophaceous Gout

77 locations incl. Birmingham

Sponsor: Crystalys Therapeutics

Sex: All·Age: 18 - 75

Code: NCT07089888·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

for Osteoarthritis

26 locations incl. Phoenix

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07153471·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for Metastatic Colorectal Cancer (CRC)

94 locations incl. Mobile

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT07228832·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

for Menstrual Migraine

32 locations incl. Phoenix

Sponsor: Pfizer

Sex: Female·Age: 18 - 45

Code: NCT06641466·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for Transthyretin Amyloidosis With Cardiomyopathy

42 locations incl. La Jolla

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18 - 85

Code: NCT07052903·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for Non-Small Cell Lung Cancer

94 locations incl. Chandler

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for Obesity

19 locations incl. Phoenix

Sponsor: Novo Nordisk A/S

Sex: All·Age: 18+

Code: NCT07481630·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

for Hepatocellular Carcinoma (HCC)

13 locations incl. Birmingham

Sponsor: RayzeBio, Inc.

Sex: All·Age: 18+

Code: NCT06726161·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Prospective Sub-Study of the Global Hypophosphatasia Registry

for Hypophosphatasia

12 locations incl. Hartford

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: All ages

Code: NCT05234567·Recruiting·Listed Feb 2022

Apply to this trial

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

for Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)

9 locations incl. New Haven

Sponsor: Arvinas Inc.

Sex: All·Age: 18+

Code: NCT06393738·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

for Respiratory Syncytial Virus Immunization

17 locations incl. Gadsden

Sponsor: Sanofi

Sex: All·Age: 60+·Accepts healthy volunteers

Code: NCT07734649·Phase 1, Phase 2·Recruiting·Listed Jul 29, 2026

Apply to this trial

Get new-trial alerts for Charlottesville Medical Research

We'll email you whenever a new clinical trial starts recruiting at this research site in Charlottesville, VA. Unsubscribe anytime.

More research sites in Charlottesville

University of Virginia (185 trials)
University of Virginia Cancer Center (84 trials)
University of Virginia Health System (50 trials)
University of Virginia Medical Center (22 trials)
University of Virginia Comprehensive Cancer Center (13 trials)
UVA Health (8 trials)
UVA Comprehensive Cancer Center (5 trials)
UVA Medical Center (5 trials)
University of Virginia Center for Diabetes Technology (5 trials)
University of Virginia School of Medicine (5 trials)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Charlottesville, VA · Virginia clinical trials